English

Getinge Group Interim report January – September 2014

Report this content

Reporting period January – September

  • Order intake increased 3.1% to SEK 19,042 M (18,464), and declined 0.2% organically
  • Net sales rose 3.7% to SEK 18,184 M (17,530), and grew 0.4% organically
  • Profit before tax declined 58.3% to SEK 602 M (1,445)
  • Net profit declined 58.4% to SEK 439 M (1,055)
  • Earnings per share declined 58.4% to SEK 1.83 (4.40)
  • EBITA before restructuring declined 7.7% to SEK 2,496 (2,704)

Reporting period July – September 

  • Order intake rose 7.2% to SEK 6,414 M (5,981), and declined 0.2% organically
  • Net sales rose 6.4% to SEK 6,225 M (5,850), and declined 0.8% organically
  • Profit before tax declined 11.1% to SEK 505 M (568)
  • EBITA before restructuring costs increased 1.4% to SEK 920 M (907)

Third quarter of 2014

The demand for capital equipment in emerging markets improved according to plan during the quarter, although not to the anticipated extent. At the same time, growth increased slowly in the mature markets. Given the low level of growth in organic sales during the quarter, operating profit for the Group as a whole developed in a satisfactory manner

Order intake

The trend for the Group’s order intake was weak during the quarter and declined organically by 0.2%. As expected, the order intake in emerging markets improved and increased organically by more than 10% during the period. The trend for the order intake in mature markets was weak during the period, particularly with respect to Western Europe and Japan.

Teleconference with CEO Johan Malmquist and CFO Ulf Grunander
October 16, 2014 at 10:00 a.m. Swedish time
Sweden: +46 (0) 8 5033 6538
UK: +44 (0)20 3427 1907
US: +1 646 254 3367
Code: 5020860

Tags:

Interim report Getinge Getinge Group Getinge Infection Control Medical Systems Getinge conference call ArjoHuntleigh Extended Care Getinge Q3 report

Subscribe

Documents & Links